as on February 3, 2026 at 4:01 pm IST
Day's High
2.86%
Upside
52 Week's Low
52 Week's High
19.81%
Downside
250.84%
Upside
as on February 3, 2026 at 4:01 pm IST
Market Cap
₹73.13 Cr
Return on Equity (ROE)
0PE Ratio (TTM)
-3
Return on capital employed (ROCE)
0Industry PE ratio
39.84
Beta (LTM)
-2.2
P/B Ratio
0Dividend Yield
0PEG Ratio
-3.61
Quarterly Earnings Growth YOY
42.02
EPS (TTM)
0Sector
Pharmaceuticals
Book Value
0Technical Analysis
Bearish
View Technical Analysis
as on February 3, 2026 at 4:01 pm IST
Vivimed Labs in the last 5 years
Lowest (-23.54x)
September 30, 2019
Today (-3.00x)
February 2, 2026
Industry (39.84x)
February 2, 2026
Highest (8.71x)
April 3, 2018
Today’s Price to Earnings Ratio: -3.00x
Compare market cap, revenue, PE, and other key metrics of Vivimed Labs with its industry peers.
Company | Analyst View | Market Cap(in ₹ Cr) | 5 Year CAGR | Debt to Asset Ratio | Net Profit(in ₹ Cr) | Yearly Revenue(in ₹ Cr) |
|---|---|---|---|---|---|---|
| NA | 73.13 | -9.11% | 1.02 | -32 | 116 | |
| NA | 42.73 | 11.93% | 0.69 | 2 | 71 | |
| BUY | 3,419.74 | 15.73% | 0.56 | 95 | 921 | |
| NA | 5.78 | -3.51% | 0.00 | -2 | 13 | |
| NA | 489.89 | -6.91% | 0.57 | 6 | 162 |
Get share price movements and forecasts by analysts on Vivimed Labs.
Source: S&P Global Market Intelligence
Search interest for Vivimed Labs Ltd Stock has increased by 75% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:75% versus previous 30 day period
Figures in Rupees Crores
Figures in Rupees Crores
Figures in Rupees Crores
View detailed summary of the earnings and dividend history of Vivimed Labs.
Vivimed Labs Ltd’s net profit fell -42.02% since last year same period to ₹-7.30Cr in the Q2 2025-2026. On a quarterly growth basis, Vivimed Labs Ltd has generated -32.97% fall in its net profits since last 3-months.
Read More about Earnings ResultsIn the quarter ending March 2018, Vivimed Labs Ltd has declared dividend of ₹0.40 per share on 30 May 2018 - translating a dividend yield of 4.54%.
Read More about DividendsInsights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Price Rise
![]()
In the last 7 days, VIVIMEDLAB stock has moved up by 15.0%
Against Peers
![]()
In the last 3 years, Torrent Pharmaceuticals Ltd has given 153.9% return, outperforming this stock by 163.9%
Retail Holding Unchanged
![]()
Retail Investor holdings remained unchanged at 90.48% of holdings in Dec 2025 quarter
Against Peers
![]()
In the last 1 year, Torrent Pharmaceuticals Ltd has given 17.0% return, outperforming this stock by 85.4%
Promoter Holding Unchanged
![]()
Promoters holdings remained unchanged at 7.77% of holdings in Dec 2025 quarter
FII Holding Unchanged
![]()
Foreign Institutions holdings remained unchanged at 1.64% of holdings in Dec 2025 quarter
Profit Down
![]()
Netprofit is down for the last 2 quarters, -5.49 Cr → -7.3 Cr (in ₹), with an average decrease of 33.0% per quarter
Revenue Fall
![]()
Revenue is down for the last 4 quarters, 36.58 Cr → 20.82 Cr (in ₹), with an average decrease of 16.6% per quarter
| Organisation | Vivimed Labs Ltd |
| Industry | Pharmaceuticals |
| E-voting on shares | Click here to vote |
Vivimed Labs share price today stands at ₹8.38 as on at the close of the market. Vivimed Labs share today touched a day high of ₹8.62 and a low of ₹8.38.
Vivimed Labs touched a 52 week high of ₹29.4 and a 52 week low of ₹6.72. Vivimed Labs share price today i.e. is closed at ₹8.38, which is -71.50% down from its 52 week high and 24.70% up from its 52 week low.
Vivimed Labs market capitalisation is ₹73.13 Cr as on .
To buy Vivimed Labs shares, you need to follow these steps:
Vivimed Labs trading volume is 3.26L as on . This means that 3.26L shares of Vivimed Labs were bought and sold on the stock market during today's trading session.